Showing results (1-10 of 18) with videos related to
Sort By:
Pageof 2
Pain Medicine (Malden, Mass.)|November 21, 2017
Opioid Prescribing Patterns and Patient Outcomes by Prescriber Type in the Oregon Prescription Drug Monitoring ProgramPatrick B Fink, Richard A Deyo, Sara E Hallvik, et al.Pharmacoepidemiology and Drug Safety|August 27, 2020
Identifying opioid dose reductions and discontinuation among patients with chronic opioid therapySara E Hallvik, Kirbee Johnston, Jonah Geddes, et al.The Journal of Pain|May 3, 2014
Who uses a prescription drug monitoring program and how? Insights from a statewide survey of Oregon cliniciansJessica M Irvine, Sara E Hallvik, Christi Hildebran, et al.Annals of Family Medicine|September 12, 2018
Opioid-Prescribing Continuity and Risky Opioid PrescriptionsSara E Hallvik, Peter Geissert, Wayne Wakeland, et al.Pain Medicine (Malden, Mass.)|October 31, 2016
Clinicians' Use of Prescription Drug Monitoring Programs in Clinical Practice and Decision-MakingGillian J Leichtling, Jessica M Irvine, Christi Hildebran, et al.Pain Medicine (Malden, Mass.)|March 25, 2016
Clinical Styles and Practice Policies: Influence on Communication with Patients Regarding Worrisome Prescription Drug Monitoring Program DataChristi Hildebran, Gillian Leichtling, Jessica M Irvine, et al.The Clinical Journal of Pain|November 8, 2014
Leading a Horse to Water: Facilitating Registration and Use of a Prescription Drug Monitoring ProgramRichard A Deyo, Jessica M Irvine, Sara E Hallvik, et al.Pharmacoepidemiology and Drug Safety|June 9, 2016
Preparing a prescription drug monitoring program data set for research purposesNicole O'Kane, Sara E Hallvik, Miguel Marino, et al.Pain|April 17, 2021
Patient outcomes after opioid dose reduction among patients with chronic opioid therapySara E Hallvik, Sanae El Ibrahimi, Kirbee Johnston, et al.Pharmacoepidemiology and Drug Safety|April 29, 2021
Linkage of public health and all payer claims data for population-level opioid researchSara E Hallvik, Nazanin Dameshghi, Sanae El Ibrahimi, et al.Pageof 2